Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Array-Based Exome Enrichment
1.2.3 Enrichment of the Exome in Solution using Biotinylated Probes
1.3 Market by Application
1.3.1 Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Rare Genetic Disease
1.3.3 Genetic Testing Unsuccessful
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Whole Exome Sequencing (WES) Market Perspective (2018-2033)
2.2 Global Clinical Whole Exome Sequencing (WES) Growth Trends by Region
2.2.1 Clinical Whole Exome Sequencing (WES) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Clinical Whole Exome Sequencing (WES) Historic Market Size by Region (2018-2023)
2.2.3 Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2024-2033)
2.3 Clinical Whole Exome Sequencing (WES) Market Dynamics
2.3.1 Clinical Whole Exome Sequencing (WES) Industry Trends
2.3.2 Clinical Whole Exome Sequencing (WES) Market Drivers
2.3.3 Clinical Whole Exome Sequencing (WES) Market Challenges
2.3.4 Clinical Whole Exome Sequencing (WES) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Whole Exome Sequencing (WES) by Players
3.1.1 Global Clinical Whole Exome Sequencing (WES) Revenue by Players (2018-2023)
3.1.2 Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Whole Exome Sequencing (WES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Whole Exome Sequencing (WES), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio
3.4.1 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Whole Exome Sequencing (WES) Revenue in 2022
3.5 Global Key Players of Clinical Whole Exome Sequencing (WES) Head office and Area Served
3.6 Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
3.7 Global Key Players of Clinical Whole Exome Sequencing (WES), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Whole Exome Sequencing (WES) Breakdown Data by Type
4.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Type (2018-2023)
4.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2024-2033)
5 Clinical Whole Exome Sequencing (WES) Breakdown Data by Application
5.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Application (2018-2023)
5.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
6.2 North America Clinical Whole Exome Sequencing (WES) Market Size by Type
6.2.1 North America Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
6.2.2 North America Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
6.2.3 North America Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
6.3 North America Clinical Whole Exome Sequencing (WES) Market Size by Application
6.3.1 North America Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
6.3.2 North America Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
6.3.3 North America Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
6.4 North America Clinical Whole Exome Sequencing (WES) Market Size by Country
6.4.1 North America Clinical Whole Exome Sequencing (WES) Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
6.4.3 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
7.2 Europe Clinical Whole Exome Sequencing (WES) Market Size by Type
7.2.1 Europe Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
7.2.2 Europe Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
7.2.3 Europe Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
7.3 Europe Clinical Whole Exome Sequencing (WES) Market Size by Application
7.3.1 Europe Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
7.3.2 Europe Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
7.3.3 Europe Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
7.4 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country
7.4.1 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
7.4.3 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
8.2 China Clinical Whole Exome Sequencing (WES) Market Size by Type
8.2.1 China Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
8.2.2 China Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
8.2.3 China Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
8.3 China Clinical Whole Exome Sequencing (WES) Market Size by Application
8.3.1 China Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
8.3.2 China Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
8.3.3 China Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
9.2 Asia Clinical Whole Exome Sequencing (WES) Market Size by Type
9.2.1 Asia Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
9.2.2 Asia Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
9.2.3 Asia Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
9.3 Asia Clinical Whole Exome Sequencing (WES) Market Size by Application
9.3.1 Asia Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
9.3.2 Asia Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
9.3.3 Asia Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
9.4 Asia Clinical Whole Exome Sequencing (WES) Market Size by Region
9.4.1 Asia Clinical Whole Exome Sequencing (WES) Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023)
9.4.3 Asia Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 CentoXome
11.1.1 CentoXome Company Details
11.1.2 CentoXome Business Overview
11.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Introduction
11.1.4 CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.1.5 CentoXome Recent Developments
11.2 Mayo Clinic Laboratories
11.2.1 Mayo Clinic Laboratories Company Details
11.2.2 Mayo Clinic Laboratories Business Overview
11.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Introduction
11.2.4 Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.2.5 Mayo Clinic Laboratories Recent Developments
11.3 Baylor Genetics
11.3.1 Baylor Genetics Company Details
11.3.2 Baylor Genetics Business Overview
11.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.3.4 Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.3.5 Baylor Genetics Recent Developments
11.4 Blueprint Genetics
11.4.1 Blueprint Genetics Company Details
11.4.2 Blueprint Genetics Business Overview
11.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.4.4 Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.4.5 Blueprint Genetics Recent Developments
11.5 GeneDx
11.5.1 GeneDx Company Details
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Introduction
11.5.4 GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.5.5 GeneDx Recent Developments
11.6 CD Genomics
11.6.1 CD Genomics Company Details
11.6.2 CD Genomics Business Overview
11.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.6.4 CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.6.5 CD Genomics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Clinical Whole Exome Sequencing (WES) Introduction
11.7.4 Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.7.5 Illumina Recent Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Details
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Introduction
11.8.4 Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.8.5 Thermo Fisher Recent Developments
11.9 Labassure
11.9.1 Labassure Company Details
11.9.2 Labassure Business Overview
11.9.3 Labassure Clinical Whole Exome Sequencing (WES) Introduction
11.9.4 Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.9.5 Labassure Recent Developments
11.10 Yale Medicine
11.10.1 Yale Medicine Company Details
11.10.2 Yale Medicine Business Overview
11.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Introduction
11.10.4 Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.10.5 Yale Medicine Recent Developments
11.11 Genosalut
11.11.1 Genosalut Company Details
11.11.2 Genosalut Business Overview
11.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Introduction
11.11.4 Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.11.5 Genosalut Recent Developments
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Introduction
11.12.4 Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.12.5 Caris Life Sciences Recent Developments
11.13 InterGenetics
11.13.1 InterGenetics Company Details
11.13.2 InterGenetics Business Overview
11.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Introduction
11.13.4 InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.13.5 InterGenetics Recent Developments
11.14 Genomics and Pathology Services (GPS)
11.14.1 Genomics and Pathology Services (GPS) Company Details
11.14.2 Genomics and Pathology Services (GPS) Business Overview
11.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Introduction
11.14.4 Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.14.5 Genomics and Pathology Services (GPS) Recent Developments
11.15 3billion
11.15.1 3billion Company Details
11.15.2 3billion Business Overview
11.15.3 3billion Clinical Whole Exome Sequencing (WES) Introduction
11.15.4 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.15.5 3billion Recent Developments
11.16 Broad Genomic
11.16.1 Broad Genomic Company Details
11.16.2 Broad Genomic Business Overview
11.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Introduction
11.16.4 Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.16.5 Broad Genomic Recent Developments
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Clinical Whole Exome Sequencing (WES) Introduction
11.17.4 Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.17.5 Roche Recent Developments
11.18 Novogene
11.18.1 Novogene Company Details
11.18.2 Novogene Business Overview
11.18.3 Novogene Clinical Whole Exome Sequencing (WES) Introduction
11.18.4 Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.18.5 Novogene Recent Developments
11.19 BGI Genomics
11.19.1 BGI Genomics Company Details
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.19.4 BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.19.5 BGI Genomics Recent Developments
11.20 Shanghai Jingzhou Genomics
11.20.1 Shanghai Jingzhou Genomics Company Details
11.20.2 Shanghai Jingzhou Genomics Business Overview
11.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.20.4 Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.20.5 Shanghai Jingzhou Genomics Recent Developments
11.21 Shihe Gene Biotechnology
11.21.1 Shihe Gene Biotechnology Company Details
11.21.2 Shihe Gene Biotechnology Business Overview
11.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Introduction
11.21.4 Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.21.5 Shihe Gene Biotechnology Recent Developments
11.22 JUNO Genomics
11.22.1 JUNO Genomics Company Details
11.22.2 JUNO Genomics Business Overview
11.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.22.4 JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.22.5 JUNO Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Array-Based Exome Enrichment
Table 3. Key Players of Enrichment of the Exome in Solution using Biotinylated Probes
Table 4. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2018-2023)
Table 8. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2024-2033)
Table 10. Clinical Whole Exome Sequencing (WES) Market Trends
Table 11. Clinical Whole Exome Sequencing (WES) Market Drivers
Table 12. Clinical Whole Exome Sequencing (WES) Market Challenges
Table 13. Clinical Whole Exome Sequencing (WES) Market Restraints
Table 14. Global Clinical Whole Exome Sequencing (WES) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Clinical Whole Exome Sequencing (WES) Revenue Share by Players (2018-2023)
Table 16. Global Top Clinical Whole Exome Sequencing (WES) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2022)
Table 17. Global Clinical Whole Exome Sequencing (WES) Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Clinical Whole Exome Sequencing (WES), Headquarters and Area Served
Table 20. Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
Table 21. Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2018-2023)
Table 25. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2024-2033)
Table 27. Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Clinical Whole Exome Sequencing (WES) Revenue Share by Application (2018-2023)
Table 29. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Clinical Whole Exome Sequencing (WES) Revenue Share by Application (2024-2033)
Table 31. North America Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Clinical Whole Exome Sequencing (WES) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Clinical Whole Exome Sequencing (WES) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Clinical Whole Exome Sequencing (WES) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 63. CentoXome Company Details
Table 64. CentoXome Business Overview
Table 65. CentoXome Clinical Whole Exome Sequencing (WES) Product
Table 66. CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 67. CentoXome Recent Developments
Table 68. Mayo Clinic Laboratories Company Details
Table 69. Mayo Clinic Laboratories Business Overview
Table 70. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product
Table 71. Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 72. Mayo Clinic Laboratories Recent Developments
Table 73. Baylor Genetics Company Details
Table 74. Baylor Genetics Business Overview
Table 75. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product
Table 76. Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 77. Baylor Genetics Recent Developments
Table 78. Blueprint Genetics Company Details
Table 79. Blueprint Genetics Business Overview
Table 80. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product
Table 81. Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 82. Blueprint Genetics Recent Developments
Table 83. GeneDx Company Details
Table 84. GeneDx Business Overview
Table 85. GeneDx Clinical Whole Exome Sequencing (WES) Product
Table 86. GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 87. GeneDx Recent Developments
Table 88. CD Genomics Company Details
Table 89. CD Genomics Business Overview
Table 90. CD Genomics Clinical Whole Exome Sequencing (WES) Product
Table 91. CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 92. CD Genomics Recent Developments
Table 93. Illumina Company Details
Table 94. Illumina Business Overview
Table 95. Illumina Clinical Whole Exome Sequencing (WES) Product
Table 96. Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 97. Illumina Recent Developments
Table 98. Thermo Fisher Company Details
Table 99. Thermo Fisher Business Overview
Table 100. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product
Table 101. Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 102. Thermo Fisher Recent Developments
Table 103. Labassure Company Details
Table 104. Labassure Business Overview
Table 105. Labassure Clinical Whole Exome Sequencing (WES) Product
Table 106. Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 107. Labassure Recent Developments
Table 108. Yale Medicine Company Details
Table 109. Yale Medicine Business Overview
Table 110. Yale Medicine Clinical Whole Exome Sequencing (WES) Product
Table 111. Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 112. Yale Medicine Recent Developments
Table 113. Genosalut Company Details
Table 114. Genosalut Business Overview
Table 115. Genosalut Clinical Whole Exome Sequencing (WES) Product
Table 116. Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 117. Genosalut Recent Developments
Table 118. Caris Life Sciences Company Details
Table 119. Caris Life Sciences Business Overview
Table 120. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product
Table 121. Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 122. Caris Life Sciences Recent Developments
Table 123. InterGenetics Company Details
Table 124. InterGenetics Business Overview
Table 125. InterGenetics Clinical Whole Exome Sequencing (WES) Product
Table 126. InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 127. InterGenetics Recent Developments
Table 128. Genomics and Pathology Services (GPS) Company Details
Table 129. Genomics and Pathology Services (GPS) Business Overview
Table 130. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product
Table 131. Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 132. Genomics and Pathology Services (GPS) Recent Developments
Table 133. 3billion Company Details
Table 134. 3billion Business Overview
Table 135. 3billion Clinical Whole Exome Sequencing (WES) Product
Table 136. 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 137. 3billion Recent Developments
Table 138. Broad Genomic Company Details
Table 139. Broad Genomic Business Overview
Table 140. Broad Genomic Clinical Whole Exome Sequencing (WES) Product
Table 141. Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 142. Broad Genomic Recent Developments
Table 143. Roche Company Details
Table 144. Roche Business Overview
Table 145. Roche Clinical Whole Exome Sequencing (WES) Product
Table 146. Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 147. Roche Recent Developments
Table 148. Novogene Company Details
Table 149. Novogene Business Overview
Table 150. Novogene Clinical Whole Exome Sequencing (WES) Product
Table 151. Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 152. Novogene Recent Developments
Table 153. BGI Genomics Company Details
Table 154. BGI Genomics Business Overview
Table 155. BGI Genomics Clinical Whole Exome Sequencing (WES) Product
Table 156. BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 157. BGI Genomics Recent Developments
Table 158. Shanghai Jingzhou Genomics Company Details
Table 159. Shanghai Jingzhou Genomics Business Overview
Table 160. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product
Table 161. Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 162. Shanghai Jingzhou Genomics Recent Developments
Table 163. Shihe Gene Biotechnology Company Details
Table 164. Shihe Gene Biotechnology Business Overview
Table 165. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product
Table 166. Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 167. Shihe Gene Biotechnology Recent Developments
Table 168. JUNO Genomics Company Details
Table 169. JUNO Genomics Business Overview
Table 170. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product
Table 171. JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 172. JUNO Genomics Recent Developments
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Clinical Whole Exome Sequencing (WES) Market Share by Type: 2022 VS 2033
Figure 3. Array-Based Exome Enrichment Features
Figure 4. Enrichment of the Exome in Solution using Biotinylated Probes Features
Figure 5. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Clinical Whole Exome Sequencing (WES) Market Share by Application: 2022 VS 2033
Figure 7. Rare Genetic Disease Case Studies
Figure 8. Genetic Testing Unsuccessful Case Studies
Figure 9. Others Case Studies
Figure 10. Clinical Whole Exome Sequencing (WES) Report Years Considered
Figure 11. Global Clinical Whole Exome Sequencing (WES) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Clinical Whole Exome Sequencing (WES) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Clinical Whole Exome Sequencing (WES) Market Share by Region: 2022 VS 2033
Figure 14. Global Clinical Whole Exome Sequencing (WES) Market Share by Players in 2022
Figure 15. Global Top Clinical Whole Exome Sequencing (WES) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue in 2022
Figure 17. North America Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 19. North America Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 20. North America Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 21. United States Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Clinical Whole Exome Sequencing (WES) Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 25. Europe Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 26. Europe Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 27. Germany Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Clinical Whole Exome Sequencing (WES) Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 35. China Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 36. Asia Clinical Whole Exome Sequencing (WES) Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 38. Asia Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 39. Asia Clinical Whole Exome Sequencing (WES) Market Share by Region (2018-2033)
Figure 40. Japan Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 50. Brazil Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. CentoXome Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 57. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 58. Baylor Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 59. Blueprint Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 60. GeneDx Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 61. CD Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 62. Illumina Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 63. Thermo Fisher Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 64. Labassure Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 65. Yale Medicine Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 66. Genosalut Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 67. Caris Life Sciences Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 68. InterGenetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 69. Genomics and Pathology Services (GPS) Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 70. 3billion Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 71. Broad Genomic Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 72. Roche Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 73. Novogene Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 74. BGI Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 75. Shanghai Jingzhou Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 76. Shihe Gene Biotechnology Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 77. JUNO Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed